SDF1-3′A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events

Clinical Chemistry

Volumn 51, Issue 12, 2005, Pages 2411-2414

  Gerli, GianCarla ^a   Vanelli, Chiara ^a   Turri, Olivia ^b   Erario, Maddalena ^b   Gardellini, Angelo ^a   Pugliano, Mariateresa ^a   Biondi, Maria Luisa ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale San Paolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; ALPHA CHEMOKINE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; THROMBOCYTHEMIA; THROMBOSIS; ALLELE; CHRONIC DISEASE; GENETIC POLYMORPHISM; GENETICS;

ALLELES; CHEMOKINES, CXC; CHRONIC DISEASE; GENOTYPE; HUMANS; MYELOPROLIFERATIVE DISORDERS; POLYMORPHISM, GENETIC; THROMBOSIS;

EID: 28044437125     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.057802     Document Type: Article

References (24)

1. + progenitors to peripheral blood. J Exp Med 1997;185:111-20.
2. + cells: evidence for an autocrine/paracrine mechanism. Blood 2002;99:1117-29.
3. Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V, Legrand E, et al. SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in vitro and in vivo models. Thromb Res 2000;99:587-94.
4. Bleul CC, Fuhlbrigge RC, Casanovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996;184:1101-9.
5. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000;86:131-8.
6. Gupta SK, Pillarisetti K, Lysko PG. Modulation of CXCR4 expression and SDF-1α functional activity during differentiation of human monocytes and macrophages. J Leukoc Biol 1999;66:135-43.
7. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-3.
8. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998;279:389-93.
9. + progenitor cells mobilized into peripheral blood in humans. Br J Haematol 2001;113:247-50.
10. Andréasson B, Swolin B, Kutti J. Increase of CD34 positive cells in polycythaemia vera. Eur J Haematol 1997;59:171-6.
11. + cells in myelofibrosis with myeloid metaplasia. Blood 2001;98:3249-55.
12. Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica 2003;88:1123-9.
13. Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in polycythemia vera, chronic mieloproliferative leucemia, and myelofibrosis has increased vascularity. Am J Pathol 2000;157:15-9.
14. Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 2000;96:3374-80.
15. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986;23:132-43.
16. Murphy S, Iland H, Rosenthal D, Laszo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986;23:177-82.
17. Goulis J, Chau TN, Jordan S, Metha AB, Watkinson A, Rolles K. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999;44:754-8.
18. Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Takahashi R, et al. Stromal cell-derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum Immunol 2003;64:973-8.
19. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999;93:1838-42.
20. De Oliveira Cavassin GG, De Lucca FL, Delgado André N, Covas DT, Pelegrinelli Fungaro MH, Voltarelli JC, et al. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukaemia and lymphoma patients from Brazil. Blood Cells Mol Dis 2004;33:90-3.
21. Magierowska M, Lepage V, Boubnova L, Carcassi C, de Juan D, Djoulah S, et al. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3′A variant in healthy individuals from different populations. Immunogenetics 1998;48:417-9.
22. Murphy P, Ahmed N, Hassan HT. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera. Leuk Res 2002;26:1007-10.
23. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-64.
24. Musolino C, Calabro' L, Bellomo G, Martello F, Loteta B, Pezzano C, et al. Soluble angiogenic factors: implications for chronic myeloproliferative disorders. Am J Hematol 2002;69:159-63.